Orchard Therapeutics Announces Comprehensive Presence at 19th Annual WORLDSymposium
BOSTON and LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced a series of presentations from across its neurometabolic portfolio will be featured at the 19th Annual WORLDSymposium taking place February 22-26, 2023, in Orlando, Florida.
- BOSTON and LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced a series of presentations from across its neurometabolic portfolio will be featured at the 19th Annual WORLDSymposium taking place February 22-26, 2023, in Orlando, Florida.
- “The data to be presented at WORLD 2023 represents significant progress toward our mission of ending the devastation of severe genetic diseases though the transformative potential of HSC gene therapy,” said Leslie Meltzer, Ph.D., chief medical officer of Orchard Therapeutics.
- Oral presentation details are as follows (all times in EST; * denotes corresponding poster):
Date/Time: Friday, February 24 at 8:00 a.m. - Title: A MLD newborn screening pilot-study for metachromatic leukodystrophy in Germany: Results of the first 12 months
Date/Time: Saturday, February 25 from 4:00-5:00 p.m.
Date/Time: Saturday, February 25 from 4:00-5:00 p.m.